Titan Pharmaceuticals, Inc. (Nasdaq: TTNP) announced that 10 patients received treatment last week with the Probuphine (buprenorphine) implant, making them ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE